Telehealth Stepped Alcohol Treatment Cuts Alcohol Use in Chronic Liver Disease Patients

A recent study published online on June 24 in the journal *Hepatology* reports that a stepped alcohol treatment (SAT) program delivered through telehealth can significantly reduce alcohol consumption among individuals with chronic liver disease (CLD). The research, which followed patients over a defined period, found that participants receiving the structured, tiered intervention reported lower daily intake and fewer binge episodes compared with those receiving standard care.

The SAT model combines brief counseling, motivational interviewing, and pharmacologic support, with intensity adjusted based on each patient’s progress. Telehealth delivery enabled regular virtual visits, allowing clinicians to monitor adherence, manage side effects, and provide timely adjustments without requiring in‑person appointments. The study’s findings suggest that remote, scalable interventions may help address the high rates of alcohol misuse that exacerbate liver damage and complicate treatment outcomes.

These results underscore the potential of telemedicine to improve substance‑use outcomes in liver‑disease populations. As healthcare systems increasingly adopt virtual care modalities, the SAT approach could become a valuable tool for clinicians seeking to reduce alcohol‑related morbidity among patients with chronic liver conditions.